Daito Chemix Corporation (TYO:4366)
Japan · Delayed Price · Currency is JPY 426.00
-7.00 (-1.62%)
Nov 5, 2026, 9:00 AM JST
Daito Chemix Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 20,823 | 19,476 | 18,644 | 15,811 | 16,377 | 16,134 | |
Revenue Growth | 10.12% | 4.46% | 17.92% | -3.46% | 1.51% | 15.26% |
Cost of Revenue | 18,295 | 17,258 | 16,571 | 13,911 | 13,942 | 13,205 |
Gross Profit | 2,528 | 2,218 | 2,073 | 1,900 | 2,435 | 2,929 |
Selling, General & Admin | 1,383 | 1,292 | 1,139 | 1,033 | 1,037 | 1,051 |
Research & Development | - | - | 40 | 44 | 45 | 45 |
Operating Expenses | 1,436 | 1,345 | 1,225 | 1,124 | 1,150 | 1,165 |
Operating Income | 1,092 | 873 | 848 | 776 | 1,285 | 1,764 |
Interest Expense | -95 | -75 | -47 | -39 | -41 | -21 |
Interest & Investment Income | 77 | 67 | 58 | 56 | 46 | 37 |
Earnings From Equity Investments | 145 | 48 | -14 | -1,506 | 21 | -21 |
Currency Exchange Gain (Loss) | -9 | -14 | -38 | -18 | -31 | -18 |
Other Non Operating Income (Expenses) | 23 | 15 | 21 | 23 | 27 | 42 |
EBT Excluding Unusual Items | 1,233 | 914 | 828 | -708 | 1,307 | 1,783 |
Gain (Loss) on Sale of Investments | - | - | - | 73 | - | - |
Gain (Loss) on Sale of Assets | -33 | -30 | -9 | -24 | -17 | -32 |
Legal Settlements | - | -8 | - | - | - | - |
Other Unusual Items | 85 | 137 | 34 | -19 | - | - |
Pretax Income | 1,285 | 1,013 | 853 | -678 | 1,290 | 1,751 |
Income Tax Expense | 122 | 222 | 33 | 327 | 368 | 168 |
Net Income | 1,163 | 791 | 820 | -1,005 | 922 | 1,583 |
Net Income to Common | 1,163 | 791 | 820 | -1,005 | 922 | 1,583 |
Net Income Growth | 43.23% | -3.54% | - | - | -41.76% | 44.96% |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Change | 0.00% | 0.00% | - | - | - | - |
EPS (Basic) | 36.11 | 24.56 | 25.46 | -31.21 | 28.63 | 49.15 |
EPS (Diluted) | 36.11 | 24.56 | 25.46 | -31.21 | 28.63 | 49.15 |
EPS Growth | 43.22% | -3.54% | - | - | -41.76% | 44.96% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,754 | 1,862 | -1,655 | -1,500 | -319 |
Free Cash Flow Per Share | - | 54.46 | 57.82 | -51.39 | -46.58 | -9.90 |
Dividend Per Share | 8.000 | 8.000 | 5.333 | 3.333 | 4.000 | 4.667 |
Dividend Growth | 118.19% | 50.00% | 60.00% | -16.67% | -14.29% | 16.67% |
Gross Margin | 12.14% | 11.39% | 11.12% | 12.02% | 14.87% | 18.15% |
Operating Margin | 5.24% | 4.48% | 4.55% | 4.91% | 7.85% | 10.93% |
Profit Margin | 5.58% | 4.06% | 4.40% | -6.36% | 5.63% | 9.81% |
Free Cash Flow Margin | - | 9.01% | 9.99% | -10.47% | -9.16% | -1.98% |
EBITDA | 2,444 | 2,201 | 2,325 | 2,257 | 2,083 | 2,361 |
EBITDA Margin | 11.74% | 11.30% | 12.47% | 14.27% | 12.72% | 14.63% |
D&A For EBITDA | 1,352 | 1,328 | 1,477 | 1,481 | 798 | 597 |
EBIT | 1,092 | 873 | 848 | 776 | 1,285 | 1,764 |
EBIT Margin | 5.24% | 4.48% | 4.55% | 4.91% | 7.85% | 10.93% |
Effective Tax Rate | 9.49% | 21.92% | 3.87% | - | 28.53% | 9.59% |